16:47 EDT OS Therapies (OSTX) files $100M mixed securities shelf
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSTX:
- Promising Phase 2b Results and Regulatory Advancements Drive Buy Rating for OS Therapies
- OS Therapies files to sell 3.76M shares of common stock for holders
- OS Therapies CEO Paul Romness sees ‘huge upside potential’
- OS Therapies hopes to become commercial biotech in early 2026, CEO says
- Romness sees potential FDA approval, PVR as key to OS Therapies stock